Network-based cytokine inference implicates Oncostatin M as a driver of an inflammation phenotype in knee osteoarthritis

Aging Cell. 2024 Feb;23(2):e14043. doi: 10.1111/acel.14043. Epub 2023 Dec 18.

Abstract

Inflammatory cytokines released by synovium after trauma disturb the gene regulatory network and have been implicated in the pathophysiology of osteoarthritis. A mechanistic understanding of how aging perturbs this process can help identify novel interventions. Here, we introduced network paradigms to simulate cytokine-mediated pathological communication between the synovium and cartilage. Cartilage-specific network analysis of injured young and aged murine knees revealed aberrant matrix remodeling as a transcriptomic response unique to aged knees displaying accelerated cartilage degradation. Next, network-based cytokine inference with pharmacological manipulation uncovered IL6 family member, Oncostatin M (OSM), as a driver of the aberrant matrix remodeling. By implementing a phenotypic drug discovery approach, we identified that the activation of OSM recapitulated an "inflammatory" phenotype of knee osteoarthritis and highlighted high-value targets for drug development and repurposing. These findings offer translational opportunities targeting the inflammation-driven osteoarthritis phenotype.

Keywords: Oncostatin M; aging; cartilage-specific network; cytokine inference; matrix remodeling; network propagation; osteoarthritis.

MeSH terms

  • Animals
  • Inflammation
  • Mice
  • Oncostatin M / genetics
  • Oncostatin M / metabolism
  • Osteoarthritis, Knee*
  • Phenotype

Substances

  • Oncostatin M